Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025

News > Business News

Audio By Carbonatix

7:30 AM on Wednesday, October 15

The Associated Press

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 15, 2025--

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its third quarter 2025 financial results and provide recent corporate updates on November 6, 2025, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (9:00 p.m. HKT).

Conference Call and Webcast Information

The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call.

Details are as follows:

Registration link for webcast (preferred): https://edge.media-server.com/mmc/p/svanah67
Registration link for dial-in: https://register-conf.media-server.com/register/BIc22945ac95b04071a1d7c0d81eb32021

All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-in details will be in the confirmation email which the participant will receive upon registering. A replay will be available shortly after the call and can be accessed by visiting the Company's website.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health.

For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at https://x.com/ZaiLab_Global.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251015598260/en/

CONTACT: For more information:

Investor Relations:

Christine Chiou / Cyan Liu

+1 (917) 886-6929 / +86 195 3130 8895

[email protected]/[email protected]:

Shaun Maccoun / Xiaoyu Chen

+1 (857) 270-8854 / +86 185 0015 5011

[email protected]/[email protected]

KEYWORD: CHINA UNITED STATES NORTH AMERICA ASIA PACIFIC MASSACHUSETTS

INDUSTRY KEYWORD: ONCOLOGY HEALTH RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY